APA

Ponnusamy S., Lattmann E., Lattmann P., Thiyagarajan T., Padinjarethalakal B. N. & Narayanan R. (20161226). Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action. : Oncology reports.

Chicago

Ponnusamy Suriyan, Lattmann Eric, Lattmann Pornthip, Thiyagarajan Thirumagal, Padinjarethalakal Balaram N and Narayanan Ramesh. 20161226. Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action. : Oncology reports.

Harvard

Ponnusamy S., Lattmann E., Lattmann P., Thiyagarajan T., Padinjarethalakal B. N. and Narayanan R. (20161226). Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action. : Oncology reports.

MLA

Ponnusamy Suriyan, Lattmann Eric, Lattmann Pornthip, Thiyagarajan Thirumagal, Padinjarethalakal Balaram N and Narayanan Ramesh. Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action. : Oncology reports. 20161226.